Literature DB >> 16996358

Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review.

Sameer D Saini1, Hyungjin Myra Kim, Philip Schoenfeld.   

Abstract

BACKGROUND: Current guidelines stratify patients with a personal history of adenomas as low risk (ie, 1-2 small [<10 mm] adenomas at index colonoscopy) or high risk (> or =3 small adenomas or advanced adenoma at index colonoscopy) for recurrent advanced adenomas. Guidelines recommend longer intervals between surveillance colonoscopies for low-risk patients, but physicians frequently perform surveillance colonoscopy at shorter intervals for these patients.
OBJECTIVE: Our purpose was to perform a meta-analysis about the incidence of advanced adenomas at 3-year surveillance colonoscopy among high- and low-risk patients.
METHODS: Computer searches of MEDLINE, PREMEDLINE, and EMBASE were performed to identify appropriate studies. Study selection criteria were (1) study design--prospective or registry-based study, (2) study population--patients with a personal history of adenomas, and (3) intervention--completion of surveillance colonoscopy at an interval of > or =2 years. Data were extracted on (1) incidence of advanced adenomas at surveillance colonoscopy, (2) interval between colonoscopies, and (3) risk factors associated with recurrent adenomas. After the validity of study design was assessed and independent, duplicate data extraction was performed from selected trials, summary relative risks (RR) for the incidence of advanced adenomas at 3-year colonoscopy were calculated.
RESULTS: Fifteen studies met study selection criteria, but only 5 studies stratified surveillance colonoscopy results according to findings at the index colonoscopy. Patients with > or =3 adenomas at index colonoscopy were more likely to have recurrent advanced adenomas than were patients with 1 to 2 adenomas: RR 2.52, 95% CI 1.07-5.97. Patients with adenomas with high-grade dysplasia at index colonoscopy were also at increased risk for recurrent advanced adenomas: RR 1.84, 95% CI 1.06-3.19. In the individual studies, increasing size of adenomas and increasing number of adenomas at index colonoscopy were the most commonly reported risk factors associated with recurrent advanced adenomas. No studies stratified surveillance colonoscopy results according to the definitions of low risk and high risk used in current guidelines.
CONCLUSION: Few published studies stratify the incidence of advanced adenomas at surveillance colonoscopy according to index colonoscopy findings. In the future, large prospective studies or studies using pooled data from existing randomized controlled trial databases or polyp registries should be used to better define which patients are at low risk for advanced adenoma recurrence.

Entities:  

Mesh:

Year:  2006        PMID: 16996358     DOI: 10.1016/j.gie.2006.06.057

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  50 in total

1.  Urinary prostaglandin E2 metabolite and risk for colorectal adenoma.

Authors:  Martha J Shrubsole; Qiuyin Cai; Wanqing Wen; Ginger Milne; Walter E Smalley; Zhi Chen; Reid M Ness; Wei Zheng
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-13

2.  Characteristics of advanced- and non advanced sporadic polypoid colorectal adenomas: correlation to KRAS mutations.

Authors:  Enkh-Amar Yadamsuren; Szilvia Nagy; Laszlo Pajor; Agnes Lacza; Barna Bogner
Journal:  Pathol Oncol Res       Date:  2012-06-23       Impact factor: 3.201

3.  Awareness of postpolypectomy surveillance guidelines: a nationwide survey of colonoscopists in Canada.

Authors:  Harmke van Kooten; Vincent de Jonge; Eline Schreuders; Jerome Sint Nicolaas; Monique E van Leerdam; Ernst J Kuipers; Sander J O Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2012-02       Impact factor: 3.522

Review 4.  Risk of Advanced Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality in People With Low-Risk Adenomas at Baseline Colonoscopy: A Systematic Review and Meta-Analysis.

Authors:  Catherine Dubé; Mafo Yakubu; Bronwen R McCurdy; Andrea Lischka; Anna Koné; Meghan J Walker; Leslea Peirson; Jill Tinmouth
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

5.  A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.

Authors:  María Elena Martínez; John A Baron; David A Lieberman; Arthur Schatzkin; Elaine Lanza; Sidney J Winawer; Ann G Zauber; Ruiyun Jiang; Dennis J Ahnen; John H Bond; Timothy R Church; Douglas J Robertson; Stephanie A Smith-Warner; Elizabeth T Jacobs; David S Alberts; E Robert Greenberg
Journal:  Gastroenterology       Date:  2008-12-09       Impact factor: 22.682

Review 6.  Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms.

Authors:  Izumi Inoue; Jun Kato; Hideyuki Tamai; Mikitaka Iguchi; Takao Maekita; Noriko Yoshimura; Masao Ichinose
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  Risk of Metachronous Advanced Neoplasia in Patients With Multiple Diminutive Adenomas.

Authors:  Jung Yoon Kim; Tae Jun Kim; Sun-Young Baek; Soohyun Ahn; Eun Ran Kim; Sung Noh Hong; Dong Kyung Chang; Young-Ho Kim
Journal:  Am J Gastroenterol       Date:  2018-08-03       Impact factor: 10.864

8.  Physician reminders to promote surveillance colonoscopy for colorectal adenomas: a randomized controlled trial.

Authors:  John Z Ayanian; Thomas D Sequist; Alan M Zaslavsky; Richard S Johannes
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

9.  Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study.

Authors:  Samir Gupta; Han Sun; Sang Yi; Joy Storm; Guanghua Xiao; Bijal A Balasubramanian; Song Zhang; Raheela Ashfaq; Don C Rockey
Journal:  Cancer Prev Res (Phila)       Date:  2014-08-04

10.  Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics.

Authors:  Douglas J Robertson; Carol A Burke; H Gilbert Welch; Robert W Haile; Robert S Sandler; E Robert Greenberg; Dennis J Ahnen; Robert S Bresalier; Richard I Rothstein; Bernard Cole; Leila A Mott; John A Baron
Journal:  Ann Intern Med       Date:  2009-07-21       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.